Cerebrovascular disease and the pathophysiology of obstructive sleep apnea

Current Neurology and Neuroscience Reports

Volumn 7, Issue 2, 2007, Pages 173-179

  Culebras, Antonio ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REHABILITATION CARE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; SUDDEN DEATH; TRACHEOTOMY;

CARDIOVASCULAR DISEASES; HUMANS; INCIDENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 33947258001     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-007-0014-6     Document Type: Review

References (53)

1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
2. Culebras A: Balancing sleep and breathing. Stroke 2001, 32:1277-1278.
3. American Academy of Sleep Medicine: International Classification of Sleep Disorders, edn 2. Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
4. Andreotti F, Davies GJ, Hackett DR, et al.: Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988, 62:635-637.
5. Tofler GH, Brezinsky D, Schafer R, et al.: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987, 316:1514-1515.
6. Argentino C, Toni D, Rasura M, et al.: Circadian variation in the frequency of ischemic stroke. Stroke 1990, 21:387-389.
7. Kario K, Shimada K, Pickering TG: Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 2003, 41 (Suppl 1):S61-66.
8. Giles TD: Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens Suppl 2006, 24:S11-16.
9. Omama S, Yoshida Y, Ogawa A, et al.: Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psychiatry 2006, 77:1345-1349.
10. Marler JR, Price TR, Clark GL, et al.: Morning increase in onset of ischemic stroke. Stroke 1989, 20:473-476.
11. Marsh EE, Biller J, Adams HP, et al.: Circadian variation in onset of acute ischemic stroke. Arch Neurol 1990, 47:1178-1180.
12. Guilleminault C: EEG arousals: scoring rules and examples. Sleep 1992, 15:173-184.
13. Harper RM, Richard CA, Henderson LA, et al.: Structural mechanisms underlying autonomic reactions in pediatric arousal. Sleep Med 2002, 2(Suppl):S53-56.
14. Cruz-Sánchez FF, Lucena J, Ascaso C, et al.: Cerebellar cortex delayed maturation in sudden infant death syndrome. J Neuropathol Exp Neurol 1997, 56:340-346.
15. Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283:1829-1836.
16. Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
17. Lavie P, Herer P, Hoffstein V: Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320:479-482.
18. Culebras A: REM-sleep related diaphragmatic insufficiency. Neurology 1998, 50(Suppl 4):393-394.
19. Okosun IS, Prewitt TE, Cooper RS: Abdominal obesity in the United States: prevalence and attributable risk of hypertension. J Hum Hypertens 1999, 13:425-430.
20. Logan AG, Perlikowski SM, Mente A, et al.: High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
21. Sharabi Y, Dagan Y, Grossman E: Sleep apnea as a risk factor for hypertension. Curr Opin Nephrol Hypertens 2004, 13:359-364.
22. Flemons WW, Remmers JE, Gillis AM: Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis 1993, 148:618-621.
23. Guilleminault C, Pool P, Motta J, Gillis AM: Sinus arrest during REM sleep in young adults. N Engl J Med 1984, 311:1006-1010.
24. Guilleminault C, Connolly SC, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983, 52:490-494.
25. Culebras A: Stroke and sleep disorders. In Current Review of Cerebrovascular Disease, edo 2. Edited by Fisher M, Bogousslavsky J. Philadelphia: Current Medicine; 1996.
26. Rostagno C, Taddei T, Paladini B, et al.: The onset of symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia is characterized by different circadian rhythms. Am J Cardiol 1993, 71:453-455.
27. Yamashita T, Murakawa Y, Sezaki K, et al.: Circadian variation of paroxysmal atrial fibrillation. Circulation 1997, 96:1537-1541.
28. Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364-367.
29. Mooe T, Gullsby S, Rabben T, et al.: Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary bypass surgery. Coron Artery Dis 1996, 7:475-478.
30. Peker Y, Hedner J, Norum E, et al.: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159-165.
31. Naughton MT, Bradley TD: Sleep apnea in congestive heart failure. Clin Chest Med 1998, 19:99-113.
32. Beelke M, Angeli S, Del Sette M, et al.: Prevalence of patent foramen ovale in sublects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003, 4:219-223.
33. Yokoe T, Minoguchi K, Matsuo H, et al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129-1134.
34. Svatikova A, Wolk R, Magera MJ, et al.: Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 2004, 25:1325-1329.
35. Sanner BM, Konermann M, Tepel M, et al.: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000, 16:648-652.
36. Robinson GV, Pepperell JC, Segal HC, et al.: Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004, 59:777-782.
37. Netzer N, Werner P, Jochums I, et al.: Blood flow of the middle cerebral artery with sleep-disordered breathing. Correlation with obstructive hypopneas. Stroke 1998, 29:87-93.
38. Franklin KA: Cerebral hemodynamics in obstructive sleep apnea and Cheyne-Stokes respirations. Sleep Med Rev 2002, 6:429-434.
39. Neau JP, Paquereau J, Meurice JC, et al.: Auditory event-related potentials before and after treatment with nasal continuous positive airway pressure in sleep apnea syndrome. Eur J Neurol 1996, 3:29-35.
40. Behrens S, Spengos K, Hennerici M: Acceleration of cerebral blood flow velocity in a patient with sleep apnea and intracranial arterial stenosis. Sleep Breath 2002, 6:111-114.
41. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
42. Yaggi HK, Concato J, Kernan WN, et al.: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034-2041.
43. Erkinjuntti T, Partinen M, Sulkava R, et al.: Sleep apnea in multi-infarct dementia and Alzheimer's disease. Sleep 1987, 10:419-425.
44. Harbison J, Gibson GJ, Birchall D, et al.: White matter disease and sleep-disordered breathing after acute stroke. Neurology 2003, 61:959-963.
45. Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352:1206-1214.
46. Pepperell JC, Ramdassing-Dow S, Crosthwaite N, et al.: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204-210.
47. Becker H, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
48. Gotsopoulos H, Kelly JJ, Cistulli PA: Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized controlled study. Sleep 2004, 27:934-941.
49. Giles TL, Lasserson TJ, Smith BH, et al.: Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, 3:CD001106.
50. Good DC, Henkle JQ, Gelber D, et al.: Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996, 27:252-259.
51. Parra O, Arboix A, Bechich S, et al.: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375-380.
52. Hsu CY, Vennelle M, Li HY, et al.: Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006, 77:1143-1149.
53. Palombini L, Guilleminault C: Stroke and treatment with nasal CPAP. Eur J Neurol 2006, 13:198-200.